Consensus statement on chronic and subacute high altitude diseases.
about
Adaptations to local environments in modern human populationsNatural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlandersCongenital heart disease and pulmonary arterial hypertension in South America (2013 Grover Conference series)Neonatal oxygenation, pulmonary hypertension, and evolutionary adaptation to high altitude (2013 Grover Conference series)Prevalence of Chronic Mountain Sickness in high altitude districts of Himachal PradeshGenetic variation in SENP1 and ANP32D as predictors of chronic mountain sicknessAdventitial alterations are the main features in pulmonary artery remodeling due to long-term chronic intermittent hypobaric hypoxia in ratsEthnically Tibetan women in Nepal with low hemoglobin concentration have better reproductive outcomesVascular endothelial growth factor-A is associated with chronic mountain sickness in the Andean population.AltitudeOmics: rapid hemoglobin mass alterations with early acclimatization to and de-acclimatization from 5260 m in healthy humans.Burden of disease resulting from chronic mountain sickness among young Chinese male immigrants in TibetGenetic signatures reveal high-altitude adaptation in a set of ethiopian populationsPrevalence, clinical profile, iron status, and subject-specific traits for excessive erythrocytosis in andean adults living permanently at 3,825 meters above sea levelChronic mountain sickness in Chinese Han males who migrated to the Qinghai-Tibetan plateau: application and evaluation of diagnostic criteria for chronic mountain sickness.Decreased plasma soluble erythropoietin receptor in high-altitude excessive erythrocytosis and Chronic Mountain SicknessGenomic analysis of high altitude adaptation: innovations and implications.The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.Association between serum concentrations of hypoxia inducible factor responsive proteins and excessive erythrocytosis in high altitude Peru.Vascular Endothelial Growth Factor as a Prognostic Parameter in Subjects with "Plateau Red Face".Transcriptome Reveals 1400-Fold Upregulation of APOA4-APOC3 and 1100-Fold Downregulation of GIF in the Patients with Polycythemia-Induced Gastric Injury.Noninvasive Assessment of Excessive Erythrocytosis as a Screening Method for Chronic Mountain Sickness at High Altitude.Perinatal hypoxia increases susceptibility to high-altitude polycythemia and attendant pulmonary vascular dysfunction.Comparative Analysis of Gut Microbiota of Native Tibetan and Han Populations Living at Different Altitudes.Stable isotope and DNA evidence for ritual sequences in Inca child sacrifice.Acceptability, Safety, and Efficacy of Oral Administration of Extracts of Black or Red Maca (Lepidium meyenii) in Adult Human Subjects: A Randomized, Double-Blind, Placebo-Controlled StudyHigh-altitude physiology and pathophysiology: implications and relevance for intensive care medicine.Pulmonary circulation at exercise.Hypoxia facilitates neurogenic dural plasma protein extravasation in mice: a novel animal model for migraine pathophysiologyNew genetic and physiological factors for excessive erythrocytosis and Chronic Mountain SicknessBiochemistry, physiology, and complications of blood doping: facts and speculation.High-altitude Pulmonary Hypertension: an Update on Disease Pathogenesis and ManagementElevation of Circulating miR-210-3p in High-Altitude Hypoxic Environment.Sleep-disordered breathing and oxidative stress in preclinical chronic mountain sickness (excessive erythrocytosis)The Local HIF-2α/EPO Pathway in the Bone Marrow is Associated with Excessive Erythrocytosis and the Increase in Bone Marrow Microvessel Density in Chronic Mountain Sickness.Intermittent Oxygen Inhalation with Proper Frequency Improves Overall Health Conditions and Alleviates Symptoms in a Population at High Risk of Chronic Mountain Sickness with Severe SymptomsChronic Mountain Sickness: Clinical Aspects, Etiology, Management, and TreatmentIncreased Cardiometabolic Risk and Worsening Hypoxemia at High Altitude.Regulation of erythropoiesis by hypoxia-inducible factorsTime Domains of the Hypoxic Ventilatory Response and Their Molecular Basis.Chronic mountain sickness score was related with health status score but not with hemoglobin levels at high altitudes.
P2860
Q24563289-B4691FAD-86A8-436C-9CB2-0B911DBFB1B7Q24623640-02A9E067-DDE7-48F4-9E1C-E9CCD0F304DAQ26824207-EBDD481D-F5E2-4F6F-A96E-8E471F002EEDQ28085726-DDC4C3AA-3879-4AAA-910F-9188028EA7A2Q28240895-7E826753-A87C-477C-BC2D-A94130723F83Q28248051-1E1D9EB5-1A04-4BD9-8BDA-51D29897987FQ30620974-36416439-C1F6-4EB1-B9E1-28D9C3519A45Q33721268-11028F7B-E330-4AAB-903D-ACDF4173AE9BQ33820044-55B56292-5616-4B63-A6C8-92EAA822B567Q34278320-5CA10826-BA70-41F3-BFB5-99BE10F8BBC1Q34294401-DA88FB9E-C49F-465D-96FA-9161B5812AB9Q34344218-EE870647-03E3-4E62-858A-683C33373501Q34448365-F9D7EDD6-8990-453F-B0CC-942F67B5CC83Q34485873-DB65DC7C-5822-48B5-B44F-C8CC989A0215Q34626922-A7B539F6-65A2-4F18-8824-7F8AF1D52918Q34989596-DC5AF1C3-877E-47C7-95A1-EE768CB91429Q35115789-2A761299-FA9A-4972-96C1-03FD9227E6A7Q35223470-FF4F1CFE-7BAB-47EB-BB1B-F7B282FB35E3Q35814694-365D1FF6-2DF2-496F-A95D-0E6F3A51CAA0Q35814753-83055555-EAA4-49C5-84AB-A47E6BAF594BQ35814822-B079911C-45D2-4830-B377-246B025099D5Q35958620-709572AA-946D-46C6-BC9D-69220D2ABECBQ36032398-3CDCC41E-B225-44B5-A1BD-4E93F351A15EQ36082291-86DA7C20-0228-4C50-9F2D-C419E2013DE8Q36108996-ACB76077-3993-4ED8-826E-ACFE95D7E648Q36296544-DE9770B8-8280-4B60-ABCC-AD7519EA5018Q36344657-3E840106-453B-48D5-8592-5550B870EC8BQ36353546-A18B4506-FFFE-4D3A-90AA-1852ABE02963Q36382218-B98C8B38-5B84-45A2-B31F-39435A209B99Q36504354-7DB4C999-0868-47A8-9E4A-C53311619849Q36658602-C8CEF8BB-32E6-4CD7-B8D4-7500C0CF495AQ36661001-2D3B68E8-25D1-45E2-80B3-1145A27C34BBQ36736012-680CFC03-8056-4BD6-BBC6-B3B702DEB3D2Q36866696-A46B139B-5240-44DF-A03A-B3D2118D4E03Q36971748-F3D49F44-F1E9-46BD-938E-D1D150356E30Q37020004-504F4BD5-FB2C-45AF-9A96-BD26A124A8ABQ37020029-4F7EE46D-3B4D-4B44-906F-6A52C1CF4951Q37063716-0078F280-F6A6-42AF-8BFB-145520475002Q37069679-637B31FE-420F-4A57-881E-9E73847EE6A5Q37118429-2A94B0D0-4BBF-4382-8940-F5581C456CCF
P2860
Consensus statement on chronic and subacute high altitude diseases.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Consensus statement on chronic and subacute high altitude diseases.
@ast
Consensus statement on chronic and subacute high altitude diseases.
@en
Consensus statement on chronic and subacute high altitude diseases.
@nl
type
label
Consensus statement on chronic and subacute high altitude diseases.
@ast
Consensus statement on chronic and subacute high altitude diseases.
@en
Consensus statement on chronic and subacute high altitude diseases.
@nl
prefLabel
Consensus statement on chronic and subacute high altitude diseases.
@ast
Consensus statement on chronic and subacute high altitude diseases.
@en
Consensus statement on chronic and subacute high altitude diseases.
@nl
P2093
P50
P356
P1476
Consensus statement on chronic and subacute high altitude diseases.
@en
P2093
Dante Penaloza
Enrique Vargas
Fabiola León-Velarde
Gustavo Zubieta-Calleja
Gustavo Zubieta-Castillo
Ingrid Asmus
Jean-Paul Richalet
John T Reeves
Luciano Bernardi
Peter Hackett
P304
P356
10.1089/HAM.2005.6.147
P577
2005-01-01T00:00:00Z